Safety of mRNA-Based Vaccines for SARS CoV-2.

Barda, Beatrice; Cerny, Andreas

Barda, Beatrice; Cerny, Andreas.

Barda B; Department of Medicine, Ospedale La Carità, Locarno 6900, Switzerland.
Cerny A; Fondazione Epatocentro Ticino, Lugano 6900, Switzerland.

Chem Res Toxicol ; 34(8): 1823-1825, 2021 08 16.

Article in English | MEDLINE | ID: covidwho-1233682

ABSTRACT

ABSTRACT

SARS-CoV-2 has infected more than 100 million people, causing 2 million deaths globally. Studies on the development of a vaccine ended up with different formulations. We herein discuss the safety record of the two approved vaccines.

Subject(s)

COVID-19 Vaccines/adverse effects; COVID-19/prevention & control; SARS-CoV-2/immunology; 2019-nCoV Vaccine mRNA-1273; BNT162 Vaccine; COVID-19 Vaccines/immunology; COVID-19 Vaccines/therapeutic use; Humans; Vaccines, Synthetic/adverse effects; Vaccines, Synthetic/immunology; Vaccines, Synthetic/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Chem Res Toxicol Journal subject: Toxicology Year: 2021 Document Type: Article Affiliation country: Acs.chemrestox.1c00129

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google